Inge Dale

3.2k total citations
34 papers, 2.5k citations indexed

About

Inge Dale is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Inge Dale has authored 34 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Immunology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Inge Dale's work include S100 Proteins and Annexins (9 papers), Immune Response and Inflammation (7 papers) and Cell Adhesion Molecules Research (7 papers). Inge Dale is often cited by papers focused on S100 Proteins and Annexins (9 papers), Immune Response and Inflammation (7 papers) and Cell Adhesion Molecules Research (7 papers). Inge Dale collaborates with scholars based in Norway, United Kingdom and Netherlands. Inge Dale's co-authors include Magne K. Fagerhol, P Brandtzæg, Per Brandtzæg, Martin Steinbakk, E. Lingaas, T.O. Gabrielsen, Ottar Sjaastad, Hans Prydz, Carl Fredrik Naess‐Andresen and Berit Johne and has published in prestigious journals such as The Lancet, Annals of Oncology and European Journal of Biochemistry.

In The Last Decade

Inge Dale

34 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inge Dale Norway 22 1.2k 816 434 423 352 34 2.5k
R Miniero Italy 27 954 0.8× 724 0.9× 371 0.9× 330 0.8× 857 2.4× 165 3.8k
Richard K. Shadduck United States 33 653 0.6× 1.1k 1.3× 369 0.9× 276 0.7× 256 0.7× 117 3.8k
Ulla M. Saarinen Finland 30 576 0.5× 424 0.5× 664 1.5× 360 0.9× 267 0.8× 84 3.8k
Patricia C. Giclas United States 34 794 0.7× 1.7k 2.0× 460 1.1× 361 0.9× 135 0.4× 80 3.7k
LA Aarden Netherlands 21 619 0.5× 1.7k 2.1× 973 2.2× 349 0.8× 215 0.6× 36 3.9k
Giuseppe Cianciolo Italy 32 525 0.5× 734 0.9× 295 0.7× 322 0.8× 255 0.7× 126 2.9k
Rita Mirakian United Kingdom 31 344 0.3× 846 1.0× 412 0.9× 228 0.5× 531 1.5× 71 3.7k
I. Lorenzen Denmark 34 683 0.6× 340 0.4× 276 0.6× 379 0.9× 174 0.5× 158 4.0k
Rodney Bluestone United States 35 458 0.4× 1.2k 1.4× 506 1.2× 535 1.3× 306 0.9× 155 5.4k
Dane R. Boggs United States 33 492 0.4× 891 1.1× 311 0.7× 340 0.8× 545 1.5× 107 3.6k

Countries citing papers authored by Inge Dale

Since Specialization
Citations

This map shows the geographic impact of Inge Dale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge Dale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge Dale more than expected).

Fields of papers citing papers by Inge Dale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inge Dale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge Dale. The network helps show where Inge Dale may publish in the future.

Co-authorship network of co-authors of Inge Dale

This figure shows the co-authorship network connecting the top 25 collaborators of Inge Dale. A scholar is included among the top collaborators of Inge Dale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inge Dale. Inge Dale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Randem, Britt Grethe, Sverre Langård, Inge Dale, et al.. (2002). Cancer incidence among male Norwegian asphalt workers. American Journal of Industrial Medicine. 43(1). 88–95. 22 indexed citations
3.
Randem, Britt Grethe, Sverre Langård, Johny Kongerud, et al.. (2002). Mortality from non‐malignant diseases among male Norwegian asphalt workers. American Journal of Industrial Medicine. 43(1). 96–103. 21 indexed citations
4.
Johne, Berit, Magne K. Fagerhol, Torstein Lyberg, et al.. (1997). Functional and clinical aspects of the myelomonocyte protein calprotectin.. Molecular Pathology. 50(3). 113–123. 304 indexed citations
5.
Brandtzæg, Per, T.O. Gabrielsen, Inge Dale, et al.. (1995). The Leucocyte Protein L1 (Calprotectin): A Putative Nonspecific Defence Factor at Epithelial Surfaces. Advances in experimental medicine and biology. 371A. 201–206. 99 indexed citations
6.
Brandtzæg, P, Inge Dale, & T.O. Gabrielsen. (1992). The leucocyte protein L1 (calprotectin): usefulness as an immunohistochemical marker antigen and putative biological function. Histopathology. 21(2). 191–196. 51 indexed citations
7.
Norseth, Tor, et al.. (1991). Acute effects and exposure to organic compounds in road maintenance workers exposed to asphalt. American Journal of Industrial Medicine. 20(6). 737–744. 46 indexed citations
8.
Dale, Inge. (1990). Plasma levels of the calcium-binding LI leukocyte protein: standardization of blood collection and evaluation of reference intervals in healthy controls. Scandinavian Journal of Clinical and Laboratory Investigation. 50(8). 837–841. 28 indexed citations
9.
Steinbakk, Martin, et al.. (1990). Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. The Lancet. 336(8718). 763–765. 428 indexed citations
10.
Dale, Inge, et al.. (1989). Reproducibility of tumour typing of lung carcinomas performed according to WHO's recommendation. Apmis. 97(1-6). 351–356. 8 indexed citations
11.
Dale, Inge & P Brandtzæg. (1989). Expression of the epithelial L1 antigen as an immunohistochemical marker of squamous cell carcinoma of the lung. Histopathology. 14(5). 493–502. 29 indexed citations
12.
Norseth, Tor, et al.. (1989). Kjemisk arbeidsmiljø og helserisiko ved legging av asfaltdekker : Norset, T., Waage, J., Dale, I. Duo Research Archive (University of Oslo). 1 indexed citations
13.
Gabrielsen, T.O., P Brandtzæg, P. S. Hoel, & Inge Dale. (1988). Epithelial distribution of a myelomonocytic antigen L1 in relation to cutaneous malignancies and melanocytic naevi. British Journal of Dermatology. 118(1). 59–67. 18 indexed citations
14.
Andersson, Kristin B., Knut Sletten, H. B. Berntzen, et al.. (1988). The Leucocyte L1 Protein: Identity with the Cystic Fibrosis Antigen and the Calcium‐Binding MRP‐8 and MRP‐14 Macrophage Components. Scandinavian Journal of Immunology. 28(2). 241–245. 93 indexed citations
15.
Brandtzæg, Per, Inge Dale, & Magne K. Fagerhol. (1987). Distribution of a Formalin-Resistant Myelomonocytic Antigen (L1) in Human Tissues: II. Normal and Aberrant Occurrence in Various Epithelia. American Journal of Clinical Pathology. 87(6). 700–707. 106 indexed citations
16.
Gabrielsen, T.O., Inge Dale, Per Brandtzæg, et al.. (1986). Clinical and laboratory studies. 108 indexed citations
17.
Gabrielsen, T.O., Inge Dale, Per Brandtzæg, et al.. (1986). Epidermal and dermal distribution of a myelomonocytic antigen (L1) shared by epithelial cells in various inflammatory skin diseases. Journal of the American Academy of Dermatology. 15(2). 173–179. 68 indexed citations
18.
Dale, Inge, et al.. (1983). Purification and Partial Characterization of a Highly Immunogenic Human Leukocyte Protein, the L1 Antigen. European Journal of Biochemistry. 134(1). 1–6. 196 indexed citations
19.
Dale, Inge, et al.. (1974). EVIDENCE FOR A NEW (?), TREATABLE HEADACHE ENTITY A PRELIMINARY REPORT. Headache The Journal of Head and Face Pain. 14(2). 105–108. 133 indexed citations
20.
Dale, Inge. (1973). A Method for Preservation of Papainized and Rh‐Sensitized Red Cells. Transfusion. 13(3). 135–137. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026